<DOC>
	<DOC>NCT01028911</DOC>
	<brief_summary>This is a study to evaluate the safety, tolerability and blood levels of PF-03654746 in subjects will mild to moderate Alzheimer's disease.</brief_summary>
	<brief_title>A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Probable Alzheimer's disease Mini Mental State Examination score 1826 inclusive Aged 5585 Dementia other than Alzheimer's disease Clinically significant cardiovascular disease in the past 6 months prior to screening Creatinine clearance &lt;30 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Phase 1 Alzheimer's disease Safety Tolerability Pharmacokinetics</keyword>
</DOC>